Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05799079
Title Decitabine and Cedazuridine in Combination With Venetoclax for the Treatment of Patients Who Have Relapsed Acute Myeloid Leukemia After Donor Stem Cell Transplant
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Sanjay Mohan
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.